Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder (PGBD)

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
This is a prospective pharmacogenomics study of mood stabilizer response. The goal of this work is to identify genes associated with good response of patients with bipolar disorder to two commonly used mood stabilizing agents, lithium and valproate.
Epistemonikos ID: d97a2887e493e80cd0b08bc5f8e00be1761d6b54
First added on: May 06, 2024